These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 21956158)
1. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats. Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158 [TBL] [Abstract][Full Text] [Related]
2. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Raju J; Patlolla JM; Swamy MV; Rao CV Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963 [TBL] [Abstract][Full Text] [Related]
3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913 [TBL] [Abstract][Full Text] [Related]
5. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322 [TBL] [Abstract][Full Text] [Related]
6. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Rao CV; Hirose Y; Indranie C; Reddy BS Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Reddy BS; Rao CV; Seibert K Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats. Janakiram NB; Steele VE; Rao CV Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018 [TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057 [TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats. Janakiram NB; Mohammed A; Ravillah D; Choi CI; Zhang Y; Desai D; Amin S; Rao CV Oncol Rep; 2013 Aug; 30(2):952-60. PubMed ID: 23708609 [TBL] [Abstract][Full Text] [Related]
11. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models. Au A; Li B; Wang W; Roy H; Koehler K; Birt D Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869 [TBL] [Abstract][Full Text] [Related]
12. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579 [TBL] [Abstract][Full Text] [Related]
13. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells. Patlolla JM; Raju J; Swamy MV; Rao CV Mol Cancer Ther; 2006 Jun; 5(6):1459-66. PubMed ID: 16818504 [TBL] [Abstract][Full Text] [Related]
14. 9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats. Yasui Y; Suzuki R; Kohno H; Miyamoto S; Beppu F; Hosokawa M; Miyashita K; Tanaka T Nutr Cancer; 2007; 59(1):82-91. PubMed ID: 17927506 [TBL] [Abstract][Full Text] [Related]
15. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats. Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779 [TBL] [Abstract][Full Text] [Related]
16. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Tanaka T; Kohno H; Shimada R; Kagami S; Yamaguchi F; Kataoka S; Ariga T; Murakami A; Koshimizu K; Ohigashi H Carcinogenesis; 2000 Jun; 21(6):1183-9. PubMed ID: 10837008 [TBL] [Abstract][Full Text] [Related]
17. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats. Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582 [TBL] [Abstract][Full Text] [Related]
18. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217 [TBL] [Abstract][Full Text] [Related]
19. S-adenosyl L-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture. Guruswamy S; Swamy MV; Choi CI; Steele VE; Rao CV Int J Cancer; 2008 Jan; 122(1):25-30. PubMed ID: 17724725 [TBL] [Abstract][Full Text] [Related]
20. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci. Kim KP; Whitehead C; Piazza G; Wargovich MJ Anticancer Res; 2004; 24(3a):1805-11. PubMed ID: 15274359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]